Home / Investors / Startups / Immunicom

Immunicom

Immunicom is a biotechnology company.

About Immunicom

Immunicom is redefining the limits of immunotherapy through the development of innovative, non-pharmaceutical treatment approaches for cancer, inflammatory diseases, and autoimmune diseases.

Industries

Investors in Immunicom

No investors recorded yet.